Pt. Bozza et al., LIPOPOLYSACCHARIDE-INDUCED PLEURAL NEUTROPHIL ACCUMULATION DEPENDS ONMARROW NEUTROPHILS AND PLATELET-ACTIVATING-FACTOR, European journal of pharmacology. Environmental toxicology and pharmacology section, 270(2-3), 1994, pp. 143-149
The involvement of platelet-activating factor (PAF) in lipopolysacchar
ide (LPS)-induced leukocyte accumulation in the rat pleural cavity was
investigated. Intrathoracic (i.t.) injection of LPS (250 ng/cavity) i
nduced a marked increase in the number of neutrophils at 1 h, which wa
s maximum within 6-12 h, reducing after 24 h. In parallel, an increase
in blood neutrophil counts within 1-6 h, concomitantly with a reducti
on in the number of these cells in the bone marrow, was observed. The
number of eosinophils recovered from LPS-injected pleural cavity incre
ased at 12 h and was maximum within 24-48 h. No change in blood or bon
e marrow eosinophil counts was detected. The pretreatment with WEB 208
6 or PCA 4248 (20 mg/kg) significantly inhibited pleural neutrophil ac
cumulation, blood neutrophilia and the decrease in the marrow neutroph
il content, but not eosinophil accumulation. The brood neutrophilia an
d the decrease in marrow neutrophil counts induced by the intravenous
(i.v:) injection of LPS (250 ng) were significantly lower than those o
bserved after i.t. injection. Furthermore, WEB 2086 and PCA 4248 were
ineffective against the systemic alteration induced by i.v. LPS. It wa
s concluded that LPS-induced neutrophil, but not eosinophil, accumulat
ion in the pleural cavity is related to the mobilization of neutrophil
s from the bone marrow and involves PAF dependent mechanisms.